1. Home
  2. BSLK vs GOVX Comparison

BSLK vs GOVX Comparison

Compare BSLK & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSLK
  • GOVX
  • Stock Information
  • Founded
  • BSLK 2009
  • GOVX 2001
  • Country
  • BSLK United States
  • GOVX United States
  • Employees
  • BSLK N/A
  • GOVX N/A
  • Industry
  • BSLK
  • GOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BSLK
  • GOVX Health Care
  • Exchange
  • BSLK NYSE
  • GOVX Nasdaq
  • Market Cap
  • BSLK 16.0M
  • GOVX 17.1M
  • IPO Year
  • BSLK N/A
  • GOVX N/A
  • Fundamental
  • Price
  • BSLK $0.27
  • GOVX $2.57
  • Analyst Decision
  • BSLK
  • GOVX Strong Buy
  • Analyst Count
  • BSLK 0
  • GOVX 5
  • Target Price
  • BSLK N/A
  • GOVX $14.20
  • AVG Volume (30 Days)
  • BSLK 562.2K
  • GOVX 3.6M
  • Earning Date
  • BSLK 11-07-2024
  • GOVX 11-12-2024
  • Dividend Yield
  • BSLK N/A
  • GOVX N/A
  • EPS Growth
  • BSLK N/A
  • GOVX N/A
  • EPS
  • BSLK N/A
  • GOVX N/A
  • Revenue
  • BSLK $1,489,000.00
  • GOVX $3,090,161.00
  • Revenue This Year
  • BSLK N/A
  • GOVX N/A
  • Revenue Next Year
  • BSLK N/A
  • GOVX $565.58
  • P/E Ratio
  • BSLK $0.06
  • GOVX N/A
  • Revenue Growth
  • BSLK 388.20
  • GOVX N/A
  • 52 Week Low
  • BSLK $0.23
  • GOVX $1.09
  • 52 Week High
  • BSLK $17.02
  • GOVX $11.18
  • Technical
  • Relative Strength Index (RSI)
  • BSLK N/A
  • GOVX 57.72
  • Support Level
  • BSLK N/A
  • GOVX $1.75
  • Resistance Level
  • BSLK N/A
  • GOVX $3.88
  • Average True Range (ATR)
  • BSLK 0.00
  • GOVX 0.30
  • MACD
  • BSLK 0.00
  • GOVX 0.15
  • Stochastic Oscillator
  • BSLK 0.00
  • GOVX 44.60

About BSLK BOLT PROJECTS HOLDINGS INC

Bolt Projects Holdings Inc formerly Golden Arrow Merger Corp is an shell company.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.

Share on Social Networks: